NASDAQ:VSEE 21 October 2025 - 4 November 2025

VSee Health shares surged up to 285% to $2.52 intraday on Oct. 28 after the company secured FedRAMP High security clearance from HHS. The stock closed up 209% at $1.90 and hovered near $1.50 on Oct. 29. The rally followed a $10 million teleradiology contract announced Oct. 21. Q2 2025 revenue rose 98% to $3.4 million.

VSee Health (NASDAQ: VSEE) shares jumped as much as 285% on October 28, 2025, after the company received FedRAMP High authorization from the U.S. Department of Health and Human Services. Trading volume topped 156 million shares, far above normal levels. The stock closed at $1.91, up 209%. VSee had previously surged 75% on news of a $10 million hospital contract.

VSee Health shares jumped 94% to $0.945 on Oct. 21 after announcing a multi-year teleradiology contract with a major Level-1 trauma hospital system, expected to generate $10 million over two years. Q2 2025 revenue nearly doubled year-over-year to $3.4 million, driven by the iDoc Telehealth acquisition. Analyst ratings remain bullish, with targets as high as $5. Volatility persists as VSEE trades below $1.